Global Nano-Drug Sales Market Report 2021
1 Nano-Drug Market Overview
- 1.1 Nano-Drug Product Scope
- 1.2 Nano-Drug Segment by Type
- 1.2.1 Global Nano-Drug Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Liposomes
- 1.2.3 Polymeric Micelles
- 1.2.4 Solid lipid Nanoparticles
- 1.2.5 Microemulsion and Nanoemulsion
- 1.2.6 Nanosuspension
- 1.3 Nano-Drug Segment by Application
- 1.3.1 Global Nano-Drug Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Cancer and Tumors
- 1.3.3 Autoimmune Disorders
- 1.4 Nano-Drug Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Nano-Drug Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Nano-Drug Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Nano-Drug Price Trends (2016-2027)
2 Nano-Drug Estimates and Forecasts by Region
- 2.1 Global Nano-Drug Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Nano-Drug Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Nano-Drug Sales Market Share by Region (2016-2021)
- 2.2.2 Global Nano-Drug Revenue Market Share by Region (2016-2021)
- 2.3 Global Nano-Drug Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Nano-Drug Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Nano-Drug Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Nano-Drug Estimates and Projections (2016-2027)
- 2.4.2 Europe Nano-Drug Estimates and Projections (2016-2027)
- 2.4.3 China Nano-Drug Estimates and Projections (2016-2027)
- 2.4.4 Japan Nano-Drug Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Nano-Drug Estimates and Projections (2016-2027)
- 2.4.6 India Nano-Drug Estimates and Projections (2016-2027)
3 Global Nano-Drug Competition Landscape by Players
- 3.1 Global Top Nano-Drug Players by Sales (2016-2021)
- 3.2 Global Top Nano-Drug Players by Revenue (2016-2021)
- 3.3 Global Nano-Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nano-Drug as of 2020)
- 3.4 Global Nano-Drug Average Price by Company (2016-2021)
- 3.5 Manufacturers Nano-Drug Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Nano-Drug Market Size by Type
- 4.1 Global Nano-Drug Historic Market Review by Type (2016-2021)
- 4.1.1 Global Nano-Drug Sales Market Share by Type (2016-2021)
- 4.1.2 Global Nano-Drug Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Nano-Drug Price by Type (2016-2021)
- 4.2 Global Nano-Drug Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Nano-Drug Sales Forecast by Type (2022-2027)
- 4.2.2 Global Nano-Drug Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Nano-Drug Price Forecast by Type (2022-2027)
5 Global Nano-Drug Market Size by Application
- 5.1 Global Nano-Drug Historic Market Review by Application (2016-2021)
- 5.1.1 Global Nano-Drug Sales Market Share by Application (2016-2021)
- 5.1.2 Global Nano-Drug Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Nano-Drug Price by Application (2016-2021)
- 5.2 Global Nano-Drug Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Nano-Drug Sales Forecast by Application (2022-2027)
- 5.2.2 Global Nano-Drug Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Nano-Drug Price Forecast by Application (2022-2027)
6 North America Nano-Drug Market Facts & Figures
- 6.1 North America Nano-Drug Sales by Company
- 6.1.1 North America Nano-Drug Sales by Company (2016-2021)
- 6.1.2 North America Nano-Drug Revenue by Company (2016-2021)
- 6.2 North America Nano-Drug Sales Breakdown by Type
- 6.2.1 North America Nano-Drug Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Nano-Drug Sales Breakdown by Type (2022-2027)
- 6.3 North America Nano-Drug Sales Breakdown by Application
- 6.3.1 North America Nano-Drug Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Nano-Drug Sales Breakdown by Application (2022-2027)
7 Europe Nano-Drug Market Facts & Figures
- 7.1 Europe Nano-Drug Sales by Company
- 7.1.1 Europe Nano-Drug Sales by Company (2016-2021)
- 7.1.2 Europe Nano-Drug Revenue by Company (2016-2021)
- 7.2 Europe Nano-Drug Sales Breakdown by Type
- 7.2.1 Europe Nano-Drug Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Nano-Drug Sales Breakdown by Type (2022-2027)
- 7.3 Europe Nano-Drug Sales Breakdown by Application
- 7.3.1 Europe 151 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 151 Sales Breakdown by Application (2022-2027)
8 China Nano-Drug Market Facts & Figures
- 8.1 China Nano-Drug Sales by Company
- 8.1.1 China Nano-Drug Sales by Company (2016-2021)
- 8.1.2 China Nano-Drug Revenue by Company (2016-2021)
- 8.2 China Nano-Drug Sales Breakdown by Type
- 8.2.1 China Nano-Drug Sales Breakdown by Type (2016-2021)
- 8.2.2 China Nano-Drug Sales Breakdown by Type (2022-2027)
- 8.3 China Nano-Drug Sales Breakdown by Application
- 8.3.1 China 171 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 171 Sales Breakdown by Application (2022-2027)
9 Japan Nano-Drug Market Facts & Figures
- 9.1 Japan Nano-Drug Sales by Company
- 9.1.1 Japan Nano-Drug Sales by Company (2016-2021)
- 9.1.2 Japan Nano-Drug Revenue by Company (2016-2021)
- 9.2 Japan Nano-Drug Sales Breakdown by Type
- 9.2.1 Japan Nano-Drug Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Nano-Drug Sales Breakdown by Type (2022-2027)
- 9.3 Japan Nano-Drug Sales Breakdown by Application
- 9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Nano-Drug Market Facts & Figures
- 10.1 Southeast Asia Nano-Drug Sales by Company
- 10.1.1 Southeast Asia Nano-Drug Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Nano-Drug Revenue by Company (2016-2021)
- 10.2 Southeast Asia Nano-Drug Sales Breakdown by Type
- 10.2.1 Southeast Asia Nano-Drug Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Nano-Drug Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Nano-Drug Sales Breakdown by Application
- 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)
11 India Nano-Drug Market Facts & Figures
- 11.1 India Nano-Drug Sales by Company
- 11.1.1 India Nano-Drug Sales by Company (2016-2021)
- 11.1.2 India Nano-Drug Revenue by Company (2016-2021)
- 11.2 India Nano-Drug Sales Breakdown by Type
- 11.2.1 India Nano-Drug Sales Breakdown by Type (2016-2021)
- 11.2.2 India Nano-Drug Sales Breakdown by Type (2022-2027)
- 11.3 India Nano-Drug Sales Breakdown by Application
- 11.3.1 India Nano-Drug Sales Breakdown by Application (2016-2021)
- 11.3.2 India Nano-Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Nano-Drug Business
- 12.1 Merck
- 12.1.1 Merck Corporation Information
- 12.1.2 Merck Business Overview
- 12.1.3 Merck Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Merck Nano-Drug Products Offered
- 12.1.5 Merck Recent Development
- 12.2 Pfizer
- 12.2.1 Pfizer Corporation Information
- 12.2.2 Pfizer Business Overview
- 12.2.3 Pfizer Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Pfizer Nano-Drug Products Offered
- 12.2.5 Pfizer Recent Development
- 12.3 Novartis
- 12.3.1 Novartis Corporation Information
- 12.3.2 Novartis Business Overview
- 12.3.3 Novartis Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Novartis Nano-Drug Products Offered
- 12.3.5 Novartis Recent Development
- 12.4 Abbott
- 12.4.1 Abbott Corporation Information
- 12.4.2 Abbott Business Overview
- 12.4.3 Abbott Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Abbott Nano-Drug Products Offered
- 12.4.5 Abbott Recent Development
- 12.5 GlaxoSmithKline
- 12.5.1 GlaxoSmithKline Corporation Information
- 12.5.2 GlaxoSmithKline Business Overview
- 12.5.3 GlaxoSmithKline Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 GlaxoSmithKline Nano-Drug Products Offered
- 12.5.5 GlaxoSmithKline Recent Development
- 12.6 Roche
- 12.6.1 Roche Corporation Information
- 12.6.2 Roche Business Overview
- 12.6.3 Roche Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Roche Nano-Drug Products Offered
- 12.6.5 Roche Recent Development
- 12.7 Sanofi
- 12.7.1 Sanofi Corporation Information
- 12.7.2 Sanofi Business Overview
- 12.7.3 Sanofi Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Sanofi Nano-Drug Products Offered
- 12.7.5 Sanofi Recent Development
- 12.8 Eli Lilly
- 12.8.1 Eli Lilly Corporation Information
- 12.8.2 Eli Lilly Business Overview
- 12.8.3 Eli Lilly Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 Eli Lilly Nano-Drug Products Offered
- 12.8.5 Eli Lilly Recent Development
- 12.9 Astrazeneca
- 12.9.1 Astrazeneca Corporation Information
- 12.9.2 Astrazeneca Business Overview
- 12.9.3 Astrazeneca Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Astrazeneca Nano-Drug Products Offered
- 12.9.5 Astrazeneca Recent Development
- 12.10 Johnson & Johnson
- 12.10.1 Johnson & Johnson Corporation Information
- 12.10.2 Johnson & Johnson Business Overview
- 12.10.3 Johnson & Johnson Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 Johnson & Johnson Nano-Drug Products Offered
- 12.10.5 Johnson & Johnson Recent Development
- 12.11 Celgene
- 12.11.1 Celgene Corporation Information
- 12.11.2 Celgene Business Overview
- 12.11.3 Celgene Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 Celgene Nano-Drug Products Offered
- 12.11.5 Celgene Recent Development
- 12.12 Novavax
- 12.12.1 Novavax Corporation Information
- 12.12.2 Novavax Business Overview
- 12.12.3 Novavax Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.12.4 Novavax Nano-Drug Products Offered
- 12.12.5 Novavax Recent Development
- 12.13 Stryker
- 12.13.1 Stryker Corporation Information
- 12.13.2 Stryker Business Overview
- 12.13.3 Stryker Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.13.4 Stryker Nano-Drug Products Offered
- 12.13.5 Stryker Recent Development
- 12.14 Gilead Sciences
- 12.14.1 Gilead Sciences Corporation Information
- 12.14.2 Gilead Sciences Business Overview
- 12.14.3 Gilead Sciences Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.14.4 Gilead Sciences Nano-Drug Products Offered
- 12.14.5 Gilead Sciences Recent Development
- 12.15 OSI Pharmaceuticals
- 12.15.1 OSI Pharmaceuticals Corporation Information
- 12.15.2 OSI Pharmaceuticals Business Overview
- 12.15.3 OSI Pharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.15.4 OSI Pharmaceuticals Nano-Drug Products Offered
- 12.15.5 OSI Pharmaceuticals Recent Development
- 12.16 Kadmon Pharmaceuticals
- 12.16.1 Kadmon Pharmaceuticals Corporation Information
- 12.16.2 Kadmon Pharmaceuticals Business Overview
- 12.16.3 Kadmon Pharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.16.4 Kadmon Pharmaceuticals Nano-Drug Products Offered
- 12.16.5 Kadmon Pharmaceuticals Recent Development
- 12.17 Samyang Biopharm
- 12.17.1 Samyang Biopharm Corporation Information
- 12.17.2 Samyang Biopharm Business Overview
- 12.17.3 Samyang Biopharm Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.17.4 Samyang Biopharm Nano-Drug Products Offered
- 12.17.5 Samyang Biopharm Recent Development
- 12.18 Mitsubishi Pharma
- 12.18.1 Mitsubishi Pharma Corporation Information
- 12.18.2 Mitsubishi Pharma Business Overview
- 12.18.3 Mitsubishi Pharma Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.18.4 Mitsubishi Pharma Nano-Drug Products Offered
- 12.18.5 Mitsubishi Pharma Recent Development
- 12.19 Kaken Pharmaceutical
- 12.19.1 Kaken Pharmaceutical Corporation Information
- 12.19.2 Kaken Pharmaceutical Business Overview
- 12.19.3 Kaken Pharmaceutical Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.19.4 Kaken Pharmaceutical Nano-Drug Products Offered
- 12.19.5 Kaken Pharmaceutical Recent Development
- 12.20 Selecta Biosciences
- 12.20.1 Selecta Biosciences Corporation Information
- 12.20.2 Selecta Biosciences Business Overview
- 12.20.3 Selecta Biosciences Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.20.4 Selecta Biosciences Nano-Drug Products Offered
- 12.20.5 Selecta Biosciences Recent Development
- 12.21 Par Pharmaceutical
- 12.21.1 Par Pharmaceutical Corporation Information
- 12.21.2 Par Pharmaceutical Business Overview
- 12.21.3 Par Pharmaceutical Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.21.4 Par Pharmaceutical Nano-Drug Products Offered
- 12.21.5 Par Pharmaceutical Recent Development
- 12.22 Cerulean Pharma
- 12.22.1 Cerulean Pharma Corporation Information
- 12.22.2 Cerulean Pharma Business Overview
- 12.22.3 Cerulean Pharma Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.22.4 Cerulean Pharma Nano-Drug Products Offered
- 12.22.5 Cerulean Pharma Recent Development
- 12.23 Navidea Biopharmaceuticals
- 12.23.1 Navidea Biopharmaceuticals Corporation Information
- 12.23.2 Navidea Biopharmaceuticals Business Overview
- 12.23.3 Navidea Biopharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.23.4 Navidea Biopharmaceuticals Nano-Drug Products Offered
- 12.23.5 Navidea Biopharmaceuticals Recent Development
- 12.24 Lummy
- 12.24.1 Lummy Corporation Information
- 12.24.2 Lummy Business Overview
- 12.24.3 Lummy Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.24.4 Lummy Nano-Drug Products Offered
- 12.24.5 Lummy Recent Development
13 Nano-Drug Manufacturing Cost Analysis
- 13.1 Nano-Drug Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Nano-Drug
- 13.4 Nano-Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Nano-Drug Distributors List
- 14.3 Nano-Drug Customers
15 Market Dynamics
- 15.1 Nano-Drug Market Trends
- 15.2 Nano-Drug Drivers
- 15.3 Nano-Drug Market Challenges
- 15.4 Nano-Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
The global Nano-Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nano-Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
Segment by Application
Cancer and Tumors
Autoimmune Disorders
The Nano-Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Nano-Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy